126 related articles for article (PubMed ID: 27259322)
1. The Expression of HSPD1, SCUBE3, CXCL14 and Its Relations with the Prognosis in Osteosarcoma.
Liang W; Yang C; Peng J; Qian Y; Wang Z
Cell Biochem Biophys; 2015 Dec; 73(3):763-8. PubMed ID: 27259322
[TBL] [Abstract][Full Text] [Related]
2. [Expression of chemokine CXCL14 in primary osteosarcoma and its association with prognosis].
Lu J; Wang J; Yong B; Song G; Zhao Z; Tang Q; Zou C; Yin J; Xie X; Shen J
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jun; 33(6):798-803. PubMed ID: 23803187
[TBL] [Abstract][Full Text] [Related]
3. [Role of SCUBE3 in promoting osteosarcoma cell growth and its association with prognosis].
Song G; Wang J; Lu J; Xu H; Zhao Z; Tang Q; Zou C; Yin J; Xie X; Shen J
Nan Fang Yi Ke Da Xue Xue Bao; 2014 May; 34(5):617-21. PubMed ID: 24849422
[TBL] [Abstract][Full Text] [Related]
4. XB130 expression in human osteosarcoma: a clinical and experimental study.
Wang X; Wang R; Liu Z; Hao F; Huang H; Guo W
Int J Clin Exp Pathol; 2015; 8(3):2565-73. PubMed ID: 26045762
[TBL] [Abstract][Full Text] [Related]
5. Abnormal hypermethylation of promoter region downregulates chemokine CXC ligand 14 expression in gastric cancer.
Hu C; Lin F; Zhu G; Xue X; Ding Y; Zhao Z; Zhang L; Shen X
Int J Oncol; 2013 Nov; 43(5):1487-94. PubMed ID: 23982764
[TBL] [Abstract][Full Text] [Related]
6. Expression and effect of CXCL14 in colorectal carcinoma.
Lin K; Zou R; Lin F; Zheng S; Shen X; Xue X
Mol Med Rep; 2014 Sep; 10(3):1561-8. PubMed ID: 24938992
[TBL] [Abstract][Full Text] [Related]
7. Clinical value of signal transducers and activators of transcription 3 (STAT3) gene expression in human osteosarcoma.
Wang YC; Zheng LH; Ma BA; Zhou Y; Zhang MH; Zhang DZ; Fan QY
Acta Histochem; 2011 Jul; 113(4):402-8. PubMed ID: 20546860
[TBL] [Abstract][Full Text] [Related]
8. Verification of TREX1 as a promising indicator of judging the prognosis of osteosarcoma.
Feng J; Lan R; Cai G; Lin J; Wang X; Lin J; Han D
J Orthop Surg Res; 2016 Nov; 11(1):150. PubMed ID: 27881153
[TBL] [Abstract][Full Text] [Related]
9. Platelet-derived growth factor receptor as a prognostic marker and a therapeutic target for imatinib mesylate therapy in osteosarcoma.
Kubo T; Piperdi S; Rosenblum J; Antonescu CR; Chen W; Kim HS; Huvos AG; Sowers R; Meyers PA; Healey JH; Gorlick R
Cancer; 2008 May; 112(10):2119-29. PubMed ID: 18338812
[TBL] [Abstract][Full Text] [Related]
10. DEC2 expression is positively correlated with HIF-1 activation and the invasiveness of human osteosarcomas.
Hu T; He N; Yang Y; Yin C; Sang N; Yang Q
J Exp Clin Cancer Res; 2015 Feb; 34(1):22. PubMed ID: 25884381
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional Profiling Identifies the Signaling Axes of IGF and Transforming Growth Factor-b as Involved in the Pathogenesis of Osteosarcoma.
Yang R; Piperdi S; Zhang Y; Zhu Z; Neophytou N; Hoang BH; Mason G; Geller D; Dorfman H; Meyers PA; Healey JH; Phinney DG; Gorlick R
Clin Orthop Relat Res; 2016 Jan; 474(1):178-89. PubMed ID: 26463566
[TBL] [Abstract][Full Text] [Related]
12. Decreased expression of long non-coding RNA MEG3 acts as a potential predictor biomarker in progression and poor prognosis of osteosarcoma.
Tian ZZ; Guo XJ; Zhao YM; Fang Y
Int J Clin Exp Pathol; 2015; 8(11):15138-42. PubMed ID: 26823857
[TBL] [Abstract][Full Text] [Related]
13. Cyclin-dependent kinase 9 (CDK9) is a novel prognostic marker and therapeutic target in osteosarcoma.
Ma H; Seebacher NA; Hornicek FJ; Duan Z
EBioMedicine; 2019 Jan; 39():182-193. PubMed ID: 30579871
[TBL] [Abstract][Full Text] [Related]
14. Collagen Triple Helix Repeat Containing 1 Expression in Osteosarcoma: A New Predictor of Prognosis.
Liu Y; Abulimiti N; Wang C
Ann Clin Lab Sci; 2018 May; 48(3):338-344. PubMed ID: 29970438
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of periostin gene expression via RNA interference suppressed the proliferation, apoptosis and invasion in U2OS cells.
Liu C; Huang SJ; Qin ZL
Chin Med J (Engl); 2010 Dec; 123(24):3677-83. PubMed ID: 22166650
[TBL] [Abstract][Full Text] [Related]
16. [Knockdown of cyclin A2 expression by small interfering RNA in MG-63 cells].
Liu Y; Ding JY; Shen WL; Zhao X; Fan SW
Zhonghua Zhong Liu Za Zhi; 2007 Sep; 29(9):670-5. PubMed ID: 18246796
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of ZEB1 relates to metastasis and invasion in osteosarcoma.
Shen A; Zhang Y; Yang H; Xu R; Huang G
J Surg Oncol; 2012 Jun; 105(8):830-4. PubMed ID: 22213004
[TBL] [Abstract][Full Text] [Related]
18. Chemokine CXCL14 is associated with prognosis in patients with colorectal carcinoma after curative resection.
Zeng J; Yang X; Cheng L; Liu R; Lei Y; Dong D; Li F; Lau QC; Deng L; Nice EC; Xie K; Huang C
J Transl Med; 2013 Jan; 11():6. PubMed ID: 23294544
[TBL] [Abstract][Full Text] [Related]
19. Expression of CXCL14 and its anticancer role in breast cancer.
Gu XL; Ou ZL; Lin FJ; Yang XL; Luo JM; Shen ZZ; Shao ZM
Breast Cancer Res Treat; 2012 Oct; 135(3):725-35. PubMed ID: 22910931
[TBL] [Abstract][Full Text] [Related]
20. Vitronectin significantly influences prognosis in osteosarcoma.
Shi K; Lan RL; Tao X; Wu CY; Hong HF; Lin JH
Int J Clin Exp Pathol; 2015; 8(9):11364-71. PubMed ID: 26617861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
